Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 10 papers. Top paper: “CD24Fc ameliorates immune-related adverse events while preserving anti-tumor therapeutic effect”.
Xu Wang, Xuexiang Du, Yan Zhang, Chunxia Ai, Siwen Hu‐Lieskovan +5 more
Xu Wang, Xuexiang Du, Wei Wu, Yan Zhang, Peng Zhang +8 more
Xuexiang Du, Mingyue Liu, Xu Wang, Wei Wu, Chunxia Ai +4 more
Xuexiang Du, Mingyue Liu, Xu Wang, Wei Wu, Chunxia Ai +4 more
Xuexiang Du, Mingyue Liu, Xu Wang, Wei Wu, Chunxia Ai +4 more
Xuexiang Du, Mingyue Liu, Xu Wang, Wei Wu, Chunxia Ai +4 more
Xuexiang Du, Liu Mingyue, Xu Wang, Wei Wu, Chunxia Ai +4 more
Xuexiang Du, Liu Mingyue, Xu Wang, Wei Wu, Chunxia Ai +4 more
Xuexiang Du, Mingyue Liu, Xu Wang, Wei Wu, Chunxia Ai +4 more
Xuexiang Du, Mingyue Liu, Xu Wang, Wei Wu, Chunxia Ai +4 more